Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Eledon Pharmaceuticals (ELDN) Enterprise Value (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Enterprise Value readings, the most recent being -$17.4 million for Q4 2017.

  • On a quarterly basis, Enterprise Value fell 1436.07% to -$17.4 million in Q4 2017 year-over-year; TTM through Dec 2017 was -$17.4 million, a 1436.07% decrease, with the full-year FY2017 number at -$17.4 million, down 1436.07% from a year prior.
  • Enterprise Value hit -$17.4 million in Q4 2017 for Eledon Pharmaceuticals, up from -$19.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q4 2016 to a low of -$105.5 million in Q3 2014.
  • Median Enterprise Value over the past 5 years was -$23.6 million (2013), compared with a mean of -$36.3 million.
  • Biggest five-year swings in Enterprise Value: surged 95.29% in 2016 and later tumbled 1436.07% in 2017.
  • Eledon Pharmaceuticals' Enterprise Value stood at -$31.8 million in 2013, then crashed by 231.48% to -$105.3 million in 2014, then skyrocketed by 77.18% to -$24.0 million in 2015, then surged by 95.29% to -$1.1 million in 2016, then tumbled by 1436.07% to -$17.4 million in 2017.
  • The last three reported values for Enterprise Value were -$17.4 million (Q4 2017), -$19.2 million (Q3 2017), and -$22.6 million (Q2 2017) per Business Quant data.